Opioid use in patients with polymyalgia rheumatica

Michael D. Richter, Sara J. Achenbach, Jorge A. Zamora-Legoff, Cynthia Crowson, Eric Lawrence Matteson

Research output: Contribution to journalArticle

Abstract

Objective. To examine the trends of chronic opioid use in patients with polymyalgia rheumatica (PMR) over an 11-year period in Olmsted County, Minnesota, USA and compare use to subjects without the disease. Methods. Retrospective data on opioid prescriptions were collected from 2005 to 2015 in a population-based incidence cohort of patients meeting the 2012 American College of Rheumatology classification criteria for PMR alongside comparison subjects. Poisson regression methods were used to compare opioid use between these groups. Results. 244 patients with PMR and 211 non-PMR comparator subjects were included in the study. Rates of chronic opioid use were not significantly different between the two groups. 7.5% of patients with PMR were identified as chronic users by the end of the study period compared with 5.2% of non- PMR subjects. Any opioid use was also not significantly higher in PMR, with relative risk of 1.10 (95% CI 0.97, 1.26, p=0.14). Rates of chronic use among patients over 80 years were higher in both groups. Conclusion. Patients with PMR do not appear to have higher rates of opioid use compared with the general population.

Original languageEnglish (US)
Pages (from-to)1014-1017
Number of pages4
JournalClinical and Experimental Rheumatology
Volume35
Issue number6
StatePublished - Nov 1 2017
Externally publishedYes

Fingerprint

Polymyalgia Rheumatica
Opioid Analgesics
Population
Prescriptions
Incidence

Keywords

  • Chronic pain
  • Epidemiology
  • Opioids
  • Polymyalgia rheumatica

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Richter, M. D., Achenbach, S. J., Zamora-Legoff, J. A., Crowson, C., & Matteson, E. L. (2017). Opioid use in patients with polymyalgia rheumatica. Clinical and Experimental Rheumatology, 35(6), 1014-1017.

Opioid use in patients with polymyalgia rheumatica. / Richter, Michael D.; Achenbach, Sara J.; Zamora-Legoff, Jorge A.; Crowson, Cynthia; Matteson, Eric Lawrence.

In: Clinical and Experimental Rheumatology, Vol. 35, No. 6, 01.11.2017, p. 1014-1017.

Research output: Contribution to journalArticle

Richter, MD, Achenbach, SJ, Zamora-Legoff, JA, Crowson, C & Matteson, EL 2017, 'Opioid use in patients with polymyalgia rheumatica', Clinical and Experimental Rheumatology, vol. 35, no. 6, pp. 1014-1017.
Richter MD, Achenbach SJ, Zamora-Legoff JA, Crowson C, Matteson EL. Opioid use in patients with polymyalgia rheumatica. Clinical and Experimental Rheumatology. 2017 Nov 1;35(6):1014-1017.
Richter, Michael D. ; Achenbach, Sara J. ; Zamora-Legoff, Jorge A. ; Crowson, Cynthia ; Matteson, Eric Lawrence. / Opioid use in patients with polymyalgia rheumatica. In: Clinical and Experimental Rheumatology. 2017 ; Vol. 35, No. 6. pp. 1014-1017.
@article{6e55effd3c074ced95e20efbf8648bf3,
title = "Opioid use in patients with polymyalgia rheumatica",
abstract = "Objective. To examine the trends of chronic opioid use in patients with polymyalgia rheumatica (PMR) over an 11-year period in Olmsted County, Minnesota, USA and compare use to subjects without the disease. Methods. Retrospective data on opioid prescriptions were collected from 2005 to 2015 in a population-based incidence cohort of patients meeting the 2012 American College of Rheumatology classification criteria for PMR alongside comparison subjects. Poisson regression methods were used to compare opioid use between these groups. Results. 244 patients with PMR and 211 non-PMR comparator subjects were included in the study. Rates of chronic opioid use were not significantly different between the two groups. 7.5{\%} of patients with PMR were identified as chronic users by the end of the study period compared with 5.2{\%} of non- PMR subjects. Any opioid use was also not significantly higher in PMR, with relative risk of 1.10 (95{\%} CI 0.97, 1.26, p=0.14). Rates of chronic use among patients over 80 years were higher in both groups. Conclusion. Patients with PMR do not appear to have higher rates of opioid use compared with the general population.",
keywords = "Chronic pain, Epidemiology, Opioids, Polymyalgia rheumatica",
author = "Richter, {Michael D.} and Achenbach, {Sara J.} and Zamora-Legoff, {Jorge A.} and Cynthia Crowson and Matteson, {Eric Lawrence}",
year = "2017",
month = "11",
day = "1",
language = "English (US)",
volume = "35",
pages = "1014--1017",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "6",

}

TY - JOUR

T1 - Opioid use in patients with polymyalgia rheumatica

AU - Richter, Michael D.

AU - Achenbach, Sara J.

AU - Zamora-Legoff, Jorge A.

AU - Crowson, Cynthia

AU - Matteson, Eric Lawrence

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Objective. To examine the trends of chronic opioid use in patients with polymyalgia rheumatica (PMR) over an 11-year period in Olmsted County, Minnesota, USA and compare use to subjects without the disease. Methods. Retrospective data on opioid prescriptions were collected from 2005 to 2015 in a population-based incidence cohort of patients meeting the 2012 American College of Rheumatology classification criteria for PMR alongside comparison subjects. Poisson regression methods were used to compare opioid use between these groups. Results. 244 patients with PMR and 211 non-PMR comparator subjects were included in the study. Rates of chronic opioid use were not significantly different between the two groups. 7.5% of patients with PMR were identified as chronic users by the end of the study period compared with 5.2% of non- PMR subjects. Any opioid use was also not significantly higher in PMR, with relative risk of 1.10 (95% CI 0.97, 1.26, p=0.14). Rates of chronic use among patients over 80 years were higher in both groups. Conclusion. Patients with PMR do not appear to have higher rates of opioid use compared with the general population.

AB - Objective. To examine the trends of chronic opioid use in patients with polymyalgia rheumatica (PMR) over an 11-year period in Olmsted County, Minnesota, USA and compare use to subjects without the disease. Methods. Retrospective data on opioid prescriptions were collected from 2005 to 2015 in a population-based incidence cohort of patients meeting the 2012 American College of Rheumatology classification criteria for PMR alongside comparison subjects. Poisson regression methods were used to compare opioid use between these groups. Results. 244 patients with PMR and 211 non-PMR comparator subjects were included in the study. Rates of chronic opioid use were not significantly different between the two groups. 7.5% of patients with PMR were identified as chronic users by the end of the study period compared with 5.2% of non- PMR subjects. Any opioid use was also not significantly higher in PMR, with relative risk of 1.10 (95% CI 0.97, 1.26, p=0.14). Rates of chronic use among patients over 80 years were higher in both groups. Conclusion. Patients with PMR do not appear to have higher rates of opioid use compared with the general population.

KW - Chronic pain

KW - Epidemiology

KW - Opioids

KW - Polymyalgia rheumatica

UR - http://www.scopus.com/inward/record.url?scp=85040538340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040538340&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 1014

EP - 1017

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 6

ER -